H-DL-Ala-DL-xiThr-DL-Lys-DL-Arg-OH
C19H38N8O6 — CID 18239150
Data last refreshed: (MolForge compound catalog, from PubChem)
About H-DL-Ala-DL-xiThr-DL-Lys-DL-Arg-OH
H-DL-Ala-DL-xiThr-DL-Lys-DL-Arg-OH (PubChem CID 18239150) has the molecular formula C19H38N8O6 and a molecular weight of 474.56 g/mol. Its IUPAC name is 2-[[6-amino-2-[[2-(2-aminopropanoylamino)-3-hydroxybutanoyl]amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid.
Molecular Properties
| Compound Name | H-DL-Ala-DL-xiThr-DL-Lys-DL-Arg-OH |
|---|---|
| PubChem CID | 18239150 |
| Molecular Formula | C19H38N8O6 |
| Molecular Weight | 474.56 g/mol |
| Exact Mass | 474.29 |
| IUPAC Name | 2-[[6-amino-2-[[2-(2-aminopropanoylamino)-3-hydroxybutanoyl]amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid |
| SMILES | CC(N)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)O)C(C)O |
| InChI | InChI=1S/C19H38N8O6/c1-10(21)15(29)27-14(11(2)28)17(31)25-12(6-3-4-8-20)16(30)26-13(18(32)33)7-5-9-24-19(22)23/h10-14,28H,3-9,20-21H2,1-2H3,(H,25,31)(H,26,30)(H,27,29)(H,32,33)(H4,22,23,24) |
| InChIKey | UPWDIUAJGGXPFR-UHFFFAOYSA-N |
| XLogP | -3.56 |
| TPSA | 261.27 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 474.56 |
| LogP ≤ 5 | -3.56 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 18239150 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.